Dana-Farber Cancer Institute (Site: 840139)

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Astrocytoma, Oligodendroglioma

Studies at this site

• Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma — Running, not enrolling